Skip to main content

Clinical Manifestations of Corona Virus Disease

  • Chapter
  • First Online:
Clinical Synopsis of COVID-19

Abstract

SARS-CoV-2 viral infection has been shown to infect people across all the ages and range in severity from completely asymptomatic, to symptomatic with multisystemic manifestations, to being lethal with dramatic complications. As our knowledge about COVID-19 is rapidly evolving, new and atypical symptoms are being added to the existing broad list of clinical manifestations. It is important that public healthcare professionals and clinicians are aware of the entire clinical spectrum of SARS-CoV-2 infection so as to aid prompt recognition of infected cases. Timely diagnosis can lead to appropriate isolation and treatment measures, thus helping to curb the growing menace of this global pandemic.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 84.99
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 109.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info
Hardcover Book
USD 159.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

References

  1. World Health Organization. Coronavirus disease (COVID-19) situation report – 196. https://www.who.int/docs/default-source/coronaviruse/situation-reports/20200801-covid-19-sitrep-194.pdf?sfvrsn=401287f3_2. Accessed 3 Aug 2020.

  2. Sood N, Simon P, Ebner P, et al. Seroprevalence of SARS-CoV-2-specific antibodies among adults in Los Angeles County, California, on April 10-11, 2020 [published online ahead of print, 2020 May 18]. JAMA. 2020;323(23):2425–7.

    Article  PubMed  PubMed Central  CAS  Google Scholar 

  3. Pollán M, Pérez-Gómez B, Pastor-Barriuso R, et al. Prevalence of SARS-CoV-2 in Spain (ENE-COVID): a nationwide, population-based seroepidemiological study [published online ahead of print, 2020 Jul 3]. Lancet. 2020;396:535–44. pii: S0140-6736(20)31483-5.

    Article  PubMed  PubMed Central  Google Scholar 

  4. World Health Organization (WHO). Clinical management of COVID-19. Interim guidances; 27 May 2020.

    Google Scholar 

  5. Al-Sadeq DW, Nasrallah GK. The incidence of the novel coronavirus SARS-CoV-2 among asymptomatic patients: a systematic review [published online ahead of print, 2020 Jul 2]. Int J Infect Dis. 2020;98:372–80. pii: S1201-9712(20)30533-6.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  6. Hu Z, Song C, Xu C, et al. Clinical characteristics of 24 asymptomatic infections with COVID-19 screened among close contacts in Nanjing, China. Sci China Life Sci. 2020;63(5):706–11.

    Article  CAS  PubMed  Google Scholar 

  7. Kronbichler A, Kresse D, Yoon S, Lee KH, Effenberger M, Shin JI. Asymptomatic patients as a source of COVID-19 infections: a systematic review and meta-analysis [published online ahead of print, 2020 Jun 17]. Int J Infect Dis. 2020;98:180–6.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  8. Furukawa NW, Brooks JT, Sobel J. Evidence supporting transmission of severe acute respiratory syndrome coronavirus 2 while presymptomatic or asymptomatic. Emerg Infect Dis. 2020;26(7):e201595.

    Article  PubMed Central  Google Scholar 

  9. Zhu J, Ji P, Pang J, Zhong Z, Li H, He C, Zhang J, Zhao C. Clinical characteristics of 3062 COVID-19 patients: a meta-analysis. J Med Virol. 2020. https://doi.org/10.1002/jmv.25884. Online ahead of print.

  10. Rodriguez-Morales AJ, Cardona-Ospina JA, Gutiérrez-Ocampo E, et al; Latin American Network of Coronavirus Disease 2019-COVID-19 Research (LANCOVID-19). Clinical, laboratory and imaging features of COVID-19: a systematic review and meta-analysis. Travel Med Infect Dis. 2020;34:101623. https://www.lancovid.org.

  11. Pormohammad A, Ghorbani S, Baradaran B, et al. Clinical characteristics, laboratory findings, radiographic signs and outcomes of 61,742 patients with confirmed COVID-19 infection: a systematic review and meta-analysis [published online ahead of print, 2020 Jul 15]. Microb Pathog. 2020;147:104390.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  12. Chen G, Wu D, Guo W, Cao Y, Huang D, Wang H, et al. Clinical and immunological features of severe and moderate coronavirus disease 2019. J Clin Invest. 2020;130(5):2620–9.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  13. Ludvigsson JF. Systematic review of COVID-19 in children shows milder cases and a better prognosis than adults. Acta Paediatr. 2020;109(6):1088–95.

    Article  CAS  PubMed  Google Scholar 

  14. Rui L, Sirui L, Xuebei D, Xujun Y, Yanggan W. Clinical observations in very elderly patients with COVID-19 in Wuhan. Geriatr Gerontol Int. 2020;20(7):709–14.

    Article  PubMed  Google Scholar 

  15. Guillen E, Pineiro GJ, Revuelta I, et al. Case report of COVID-19 in a kidney transplant recipient: does immunosuppression alter the clinical presentation? Am J Transplant. 2020;20(7):1875–8.

    Article  CAS  PubMed  Google Scholar 

  16. Zhou F, Yu T, Du R, Fan G, Liu Y, Liu Z, et al. Clinical course and risk factors for mortality of adult inpatients with COVID-19 in Wuhan, China: a retrospective cohort study. Lancet. 2020;395(10229):1054–62. Epub 2020/03/15.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  17. Li X, Xu S, Yu M, et al. Risk factors for severity and mortality in adult COVID-19 inpatients in Wuhan. J Allergy Clin Immunol. 2020;146(1):110–8.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  18. Guan WJ, Ni ZY, Hu Y, et al. Clinical characteristics of coronavirus disease 2019 in China. N Engl J Med. 2020;382(18):1708–20.

    Article  CAS  PubMed  Google Scholar 

  19. Burke RM, Killerby ME, Newton S, et al. Symptom profiles of a convenience sample of patients with COVID-19 - United States, January-April 2020. MMWR Morb Mortal Wkly Rep. 2020;69(28):904–8.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  20. Aggarwal A, Shrivastava A, Kumar A, Ali A. Clinical and epidemiological features of SARS-CoV-2 patients in SARI Ward of a Tertiary Care Centre in New Delhi. J Assoc Physicians India. 2020;68(7):19–26.

    PubMed  Google Scholar 

  21. Ottestad W, Seim M, Mæhlen JO. COVID-19 with silent hypoxemia. Covid-19 med stille hypoksemi. Tidsskr Nor Laegeforen. 2020;140(7). https://doi.org/10.4045/tidsskr.20.0299.

  22. Tobin MJ, Laghi F, Jubran A. Why COVID-19 silent hypoxemia is baffling to physicians. Am J Respir Crit Care Med. 2020;202(3):356–60.

    Article  PubMed  PubMed Central  Google Scholar 

  23. Wilkerson RG, Adler JD, Shah NG, Brown R. Silent hypoxia: A harbinger of clinical deterioration in patients with COVID-19 [published online ahead of print, 2020 May 22]. Am J Emerg Med. 2020;S0735-6757(20)30390-9.

    Google Scholar 

  24. Gattinoni L, Chiumello D, Caironi P, Busana M, Romitti F, Brazzi L, Camporota L. COVID-19 pneumonia: different respiratory treatments for different phenotypes? Intensive Care Med. 2020;46(6):1099–102.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  25. Ojha V, Mani A, Pandey NN, Sharma S, Kumar S. CT in coronavirus disease 2019 (COVID-19): a systematic review of chest CT findings in 4410 adult patients [published online ahead of print, 2020 May 30]. Eur Radiol. 2020;1–10.

    Google Scholar 

  26. Montalvan V, Lee J, Bueso T, De Toledo J, Rivas K. Neurological manifestations of COVID-19 and other coronavirus infections: a systematic review. Clin Neurol Neurosurg. 2020;194:105921.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  27. Mao L, Jin H, Wang M, Hu Y, Chen S, He Q, Chang J, Hong C, Zhou Y, Wang D, Miao X, Li Y, Hu B. Neurologic manifestations of hospitalized patients with coronavirus disease 2019 in Wuhan, China. JAMA Neurol. 2020;77(6):1–9.

    Article  PubMed Central  Google Scholar 

  28. Chen X, Laurent S, Onur OA, Kleineberg NN, Fink GR, Schweitzer F, Warnke C. A systematic review of neurological symptoms and complications of COVID-19. J Neurol. 2020;20:1–11.

    CAS  Google Scholar 

  29. Yachou Y, El Idrissi A, Belapasov V, Ait Benali S. Neuroinvasion, neurotropic, and neuroinflammatory events of SARS-CoV-2: understanding the neurological manifestations in COVID-19 patients. Neurol Sci. 2020;28:1–13.

    Google Scholar 

  30. Belani P, Schefflein J, Kihira S, et al. COVID-19 Is an Independent Risk Factor for Acute Ischemic Stroke [published online ahead of print, 2020 Jun 25]. AJNR Am J Neuroradiol. 2020. https://doi.org/10.3174/ajnr.A6650.

  31. Tong JY, Wong A, Zhu D, Fastenberg JH, Tham T. The prevalence of olfactory and gustatory dysfunction in COVID-19 patients: a systematic review and meta-analysis. Otolaryngol Head Neck Surg. 2020;163(1):3–11.

    Article  PubMed  Google Scholar 

  32. Lechien JR, Chiesa-Estomba CM, De Siati DR, et al. Olfactory and gustatory dysfunctions as a clinical presentation of mild-to-moderate forms of the coronavirus disease (COVID-19): a multi-center European study. Eur Arch Otorhinolaryngol. 2020;277:2251–61.

    Article  PubMed  PubMed Central  Google Scholar 

  33. Spinato G, Fabbris C, Polesel J, et al. Alterations in smell or taste in mildly symptomatic outpatients with SARS-CoV-2 infection. JAMA. 2020;323:2089–90.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  34. Vaira LA, Salzano G, Deiana G, De Riu G. Anosmia and Ageusia: common findings in COVID-19 patients. Laryngoscope. 2020 Jul;130(7):1787.

    Article  CAS  PubMed  Google Scholar 

  35. Beach SR, Praschan NC, Hogan C, et al. Delirium in COVID-19: a case series and exploration of potential mechanisms for central nervous system involvement. Gen Hosp Psychiatry. 2020;65:47–53.

    Article  PubMed  PubMed Central  Google Scholar 

  36. Nalleballe K, Reddy Onteddu S, Sharma R, et al. Spectrum of neuropsychiatric manifestations in COVID-19 [published online ahead of print, 2020 Jun 17]. Brain Behav Immun. 2020;88:71–4.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  37. Dinakaran D, Manjunatha N, Naveen Kumar C, Suresh BM. Neuropsychiatric aspects of COVID-19 pandemic: a selective review [published online ahead of print, 2020 may 30]. Asian J Psychiatr. 2020;53:102188.

    Article  PubMed  PubMed Central  Google Scholar 

  38. Li Y, Li M, Wang M, et al. Acute cerebrovascular disease following COVID-19: a single center, retrospective, observational study [published online ahead of print, 2020 Jul 2]. Stroke Vasc Neurol. 2020;svn-2020-000431.

    Google Scholar 

  39. Moriguchi T, Harii N, Goto J, et al. A frst case of meningitis/encephalitis associated with SARS-Coronavirus-2. Int J Infect Dis. 2020;94(55–58):40.

    Google Scholar 

  40. Duong L, Xu P, Liu A. Meningoencephalitis without respiratory failure in a young female patient with COVID-19 infection in downtown Los Angeles, early April 2020. Brain Behav Immun. 2020;87:33.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  41. Parsons T, Banks S, Bae C, Gelber J, Alahmadi H, Tichauer M. COVID-19-associated acute disseminated encephalomyelitis (ADEM). J Neurol. 2020;30:1–4.

    Google Scholar 

  42. Poyiadji N, Shahin G, Noujaim D, Stone M, Patel S, Griffith B. COVID-19-associated acute hemorrhagic necrotizing encephalopathy: imaging features. Radiology. 2020;296(2):E119–20.

    Article  PubMed  Google Scholar 

  43. Munz M, Wessendorf S, Koretsis G, et al. Acute transverse myelitis after COVID-19 pneumonia. J Neurol. 2020;267(8):2196–7.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  44. Paybast S, Gorji R, Mavandadi S. Guillain-Barré syndrome as a neurological complication of novel COVID-19 infection: a case report and review of the literature. Neurologist. 2020;25(4):101–3.

    Article  PubMed  Google Scholar 

  45. Zanin L, Saraceno G, Panciani PP, Renisi G, Signorini L, Migliorati K, et al. SARS-CoV-2 can induce brain and spine demyelinating lesions. Acta Neurochir. 2020;162:1491–4.

    Article  PubMed  Google Scholar 

  46. Kang Y, Chen T, Mui D, Ferrari V, Jagasia D, Scherrer-Crosbie M, Chen Y, Han Y. Cardiovascular manifestations and treatment considerations in COVID-19. Heart. 2020;106(15):1132–41.

    Article  PubMed  Google Scholar 

  47. Inciardi RM, Lupi L, Zaccone G, Italia L, Raffo M, Tomasoni D, Cani DS, Cerini M, Farina D, Gavazzi E, Maroldi R, Adamo M, Ammirati E, Sinagra G, Lombardi CM, Metra M. Cardiac involvement in a patient with coronavirus disease 2019 (COVID-19). JAMA Cardiol. 2020;5(7):1–6.

    Article  PubMed Central  Google Scholar 

  48. Ma L, Song K, Huang Y. Coronavirus disease-2019 (COVID-19) and cardiovascular complications. J Cardiothorac Vasc Anesth. 2020;S1053-0770(20)30400-6.

    Google Scholar 

  49. Tung-Chen Y. Acute pericarditis due to COVID-19 infection: an underdiagnosed disease? Med Clin (Barc). 2020;155(1):44–5.

    Article  CAS  Google Scholar 

  50. Purohit R, Kanwal A, Pandit A, Patel BM, Meininger GR, Brown JJ, Kaliyadan AG, Saini A. Acute myopericarditis with pericardial effusion and cardiac tamponade in a patient with COVID-19. Am J Case Rep. 2020;21:e925554.

    PubMed  Google Scholar 

  51. Dabbagh MF, Aurora L, D’Souza P, Weinmann AJ, Bhargava P, Basir MB. Cardiac tamponade secondary to COVID-19. JACC Case Rep. 2020;2(9):1326–30.

    Article  PubMed  PubMed Central  Google Scholar 

  52. de Carranza M, Salazar D-E, Troya J, Alcázar R, Peña C, Aragón E, Domínguez M, Torres J, Muñoz-Rivas N. Aortic thrombus in patients with severe COVID-19: review of three cases. J Thromb Thrombolysis. 2020;9:1–6.

    Google Scholar 

  53. Lushina N, Kuo JS, Shaikh HA. Pulmonary, cerebral, and renal thromboembolic disease associated with COVID-19 infection. Radiology. 2020;23:201623.

    Google Scholar 

  54. Angeli F, Spanevello A, De Ponti R, Visca D, Marazzato J, Palmiotto G, Feci D, Reboldi G, Fabbri LM, Verdecchia P. Electrocardiographic features of patients with COVID-19 pneumonia. Eur J Intern Med. 2020 20;78:101–6.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  55. Pavri BB, Kloo J, Farzad D, Riley JM. Behavior of the PR interval with increasing heart rate in patients with COVID-19. Heart Rhythm. 2020;S1547-5271(20)30551-8.

    Google Scholar 

  56. Chen Q, Xu L, Dai Y, Ling Y, Mao J, Qian J, Zhu W, Di W, Ge J. Cardiovascular manifestations in severe and critical patients with COVID-19. Clin Cardiol. 2020;43(7):796–802.

    Article  PubMed  PubMed Central  Google Scholar 

  57. Cha MH, Regueiro M, Sandhu DS. Gastrointestinal and hepatic manifestations of COVID-19: a comprehensive review. World J Gastroenterol. 2020;26(19):2323–32.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  58. Kopel J, Perisetti A, Gajendran M, Boregowda U, Goyal H. Clinical insights into the gastrointestinal manifestations of COVID-19. Dig Dis Sci. 2020;65(7):1932–9.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  59. Pan L, Mu M, Yang P, Sun Y, Wang R, Yan J, et al. Clinical characteristics of COVID-19 patients with digestive symptoms in Hubei, China: a descriptive, cross-sectional, multicenter study. Am J Gastroenterol. 2020;115(5):766–73.

    Article  PubMed  Google Scholar 

  60. Mao R, Qiu Y, He JS, Tan JY, Li XH, Liang J, Shen J, Zhu LR, Chen Y, Iacucci M, Ng SC, Ghosh S, Chen MH. Manifestations and prognosis of gastrointestinal and liver involvement in patients with COVID-19: a systematic review and meta-analysis. Lancet Gastroenterol Hepatol. 2020;5(7):667–78.

    Article  PubMed  PubMed Central  Google Scholar 

  61. Gandhi PA, Singh T. Feco-Oral transmission of SARS-CoV-2: a review. Asia Pac J Public Health. 2020;9:1010539520940931.

    Google Scholar 

  62. Zhang C, Shi L, Wang FS. Liver injury in COVID-19: management and challenges. Lancet Gastroenterol Hepatol. 2020;5:428–30.

    Article  PubMed  PubMed Central  Google Scholar 

  63. Huang J, Cheng A, Kumar R, Fang Y, Chen G, Zhu Y, Lin S. Hypoalbuminemia predicts the outcome of COVID-19 independent of age and co-morbidity. J Med Virol. 2020. https://doi.org/10.1002/jmv.26003.

  64. Samidoust P, Samidoust A, Samadani AA, Khoshdoz S. Risk of hepatic failure in COVID-19 patients. A systematic review and meta-analysis. Infez Med. 2020;28(Suppl 1):96–103.

    CAS  PubMed  Google Scholar 

  65. Lippi G, Plebani M. Laboratory abnormalities in patients with COVID-2019 infection. Clin Chem Lab Med. 2020;58(7):1131–4.

    Article  CAS  PubMed  Google Scholar 

  66. Lippi G, Plebani M, Henry BM. Thrombocytopenia is associated with severe coronavirus disease 2019 (COVID-19) infections: a meta-analysis. Clin Chim Acta. 2020;506:145–8.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  67. Chan AS, Rout A. Use of neutrophil-to-lymphocyte and platelet-to-lymphocyte ratios in COVID-19. J Clin Med Res. 2020;12(7):448–53.

    Article  PubMed  PubMed Central  Google Scholar 

  68. Tang N, Li D, Wang X, Sun Z. Abnormal coagulation parameters are associated with poor prognosis in patients with novel coronavirus pneumonia. J Thromb Haemost. 2020;18(4):844–7.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  69. Tan T, Khoo B, Mills EG, et al. Association between high serum total cortisol concentrations and mortality from COVID-19. Lancet Diabetes Endocrinol. 2020;8(8):659–60.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  70. Singh G, Sharma PK, Malviya R, Awasthi R. Novel corona virus disease (COVID-19) and ophthalmic manifestations: Clinical evidences [published online ahead of print, 2020 Jun 11]. Dermatol Ther 2020;e13814.

    Google Scholar 

  71. Wu P, Duan F, Luo C, Liu Q, Qu X, Liang L, Wu K. Characteristics of ocular findings of patients with coronavirus disease 2019 (COVID-19) in Hubei Province, China. JAMA Ophthalmol. 2020;138(5):575–8.

    Article  PubMed  PubMed Central  Google Scholar 

  72. Chen L, Liu M, Zhang Z, Qiao K, Huang T, Chen M, Xin N, Huang Z, Liu L, Zhang G, Wang J. Ocular manifestations of a hospitalised patient with confirmed 2019 novel coronavirus disease. Br J Ophthalmol. 2020;104(6):748–51.

    Article  PubMed  Google Scholar 

  73. Ozturker ZK. Conjunctivitis as sole symptom of COVID-19: a case report and review of literature. Eur J Ophthalmol. 2020;24:1120672120946287.

    Google Scholar 

  74. Kumar K, Prakash AA, Gangasagara SB, Rathod SBL, Ravi K, Rangaiah A, et al. Presence of viral RNA of SARS-CoV-2 in conjunctival swab specimens of COVID-19 patients. Indian J Ophthalmol. 2020;68(6):1015–7.

    Article  PubMed  PubMed Central  Google Scholar 

  75. Valente P, Iarossi G, Federici M, Petroni S, Palma P, Cotugno N, De Ioris MA, Campana A, Buzzonetti L. Ocular manifestations and viral shedding in tears of pediatric patients with coronavirus disease 2019: a preliminary report. J AAPOS. 2020;S1091-8531(20)30115.

    Google Scholar 

  76. Gisondi P, PIaserico S, Bordin C, Alaibac M, Girolomoni G, Naldi L. Cutaneous manifestations of SARS-CoV-2 infection: a clinical update. J Eur Acad Dermatol Venereol. 2020. https://doi.org/10.1111/jdv.16774.

  77. Davoodi L, Jafarpour H, Kazeminejad A, Soleymani E, Akbari Z, Razavi A. Hydroxychloroquine-induced Stevens-Johnson syndrome in COVID-19: a rare case report. Oxf Med Case Rep. 2020(6):omaa042. Published 2020 Jun 25.

    Google Scholar 

  78. Sinadinos A, Shelswell J. Oral ulceration and blistering in patients with COVID-19. Evid Based Dent. 2020;21(2):49.

    Article  PubMed  PubMed Central  Google Scholar 

  79. Freeman EE, McMahon DE, Lipoff JB, Rosenbach M, Kovarik C, Desai SR, et al. The spectrum of COVID-19-associated dermatologic manifestations: an international registry of 716 patients from 31 countries. J Am Acad Dermatol. 2020;S0190-9622(20)32126-5.

    Google Scholar 

  80. Galván Casas C, Català A, Carretero Hernández G, Rodríguez-Jiménez P, Fernández-Nieto D, Rodríguez-Villa Lario A, et al. Classification of the cutaneous manifestations of COVID-19: a rapid prospective nationwide consensus study in Spain with 375 cases. Br J Dermatol. 2020;183(1):71–7.

    Article  PubMed  CAS  Google Scholar 

Download references

Acknowledgments

Authors wish to acknowledge Dr. Pooja Chapegadikar and Dr. Shraya Banerjee (DNB Neuroanaesthesiology and Critical Care students at Indraprastha Apollo Hospitals, New Delhi, India) for providing the Chest Imaging findings of COVID-19 patients.

Author information

Authors and Affiliations

Authors

Editor information

Editors and Affiliations

Rights and permissions

Reprints and permissions

Copyright information

© 2020 The Editor(s) (if applicable) and The Author(s), under exclusive license to Springer Nature Singapore Pte Ltd.

About this chapter

Check for updates. Verify currency and authenticity via CrossMark

Cite this chapter

Srivastava, P., Gupta, N. (2020). Clinical Manifestations of Corona Virus Disease. In: Prabhakar, H., Kapoor, I., Mahajan, C. (eds) Clinical Synopsis of COVID-19. Springer, Singapore. https://doi.org/10.1007/978-981-15-8681-1_3

Download citation

  • DOI: https://doi.org/10.1007/978-981-15-8681-1_3

  • Published:

  • Publisher Name: Springer, Singapore

  • Print ISBN: 978-981-15-8680-4

  • Online ISBN: 978-981-15-8681-1

  • eBook Packages: MedicineMedicine (R0)

Publish with us

Policies and ethics